2020
DOI: 10.1055/a-1068-2506
|View full text |Cite
|
Sign up to set email alerts
|

First Clinical Experience with Anti-myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis

Abstract: Background Antibodies against myelin oligodendrocyte glycoprotein (MOG-IgG) have been consistently found in a range of demyelinating disorders. In this context, MOG-IgG-associated optic neuritis (ON) has been suggested as a new subset of optic neuropathy. However, clinical manifestations and distinctive characteristics have only rarely been described. Patients and Methods A retrospective case series of three patients with MOG-IgG-associated ON. Clinical morphological features using imaging techniques… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 21 publications
0
2
0
Order By: Relevance
“…Thirty-two studies were included in the systematic review 6 7 38–67. Thirteen single case reports44 45 47 48 53 55 57 58 61–63 66 67 were excluded from the quantitative analysis.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Thirty-two studies were included in the systematic review 6 7 38–67. Thirteen single case reports44 45 47 48 53 55 57 58 61–63 66 67 were excluded from the quantitative analysis.…”
Section: Resultsmentioning
confidence: 99%
“…Thirty-two studies were included in the systematic review 6 7 38–67. Thirteen single case reports44 45 47 48 53 55 57 58 61–63 66 67 were excluded from the quantitative analysis. The NOS score ranged from 3 to 9 (median: 5), indicating an overall moderate study quality.…”
Section: Resultsmentioning
confidence: 99%